SIRT1 and hepatocellular carcinoma: Additionally, studies have demonstrated that CPEB1 can directly target SIRT1, suppressing its translation and mediating cancer stemness in vitro and in vivo, suggesting its potential as a therapeutic target in hepatocellular carcinoma (HCC) (55).